For InvestorsAntares Pharma: Making Medicines Feel Better

Press Release Archive

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

2018

16 Jan 2018
Antares Pharma Provides XYOSTED Regulatory Update

15 Feb 2018
Antares Pharma Announces FDA Approval Of Partner's Product Utilizing Our Quickshot Auto Injector

26 Feb 2018
Antares Pharma to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference

01 Mar 2018
Antares Pharma Announces Receipt of Second Installment From Sale of ZOMAJET Needle-Free Delivery System

06 Mar 2018
Antares Pharma to Report Fourth Quarter and Full Year 2017 Financial and Operating Results

09 Mar 2018
Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference

13 Mar 2018
Antares Pharma Reports Fourth Quarter And Full Year 2017 Operating and Financial Results

13 Mar 2018
Antares Pharma Provides Update On The Cowen and Company 38th Annual Healthcare Conference

27 Mar 2018
Antares Pharma Provides XYOSTED Regulatory Update

05 Apr 2018
Antares Pharma Provides XYOSTED Regulatory Update

01 May 2018
Antares Pharma to Report First Quarter 2018 Financial and Operating Results

02 May 2018
Antares Pharma to Present at Deutsche Bank Securities, INC.43rd Annual Health Care Conference

08 May 2018
Antares Pharma Reports First Quarter 2018 Operating and Financial Results

30 May 2018
Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System

31 Jul 2018
Antares Pharma To Report Second Quarter 2018 Operating and Financial Results

06 Aug 2018
Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research and Development, Chief Medical Officer

06 Aug 2018
Antares Pharma Enters into a Development Agreement with Pfizer INC.

07 Aug 2018
Antares Pharma Reports Second Quarter 2018 Operating and Financial Results

16 Aug 2018
Antares Pharma Announces FDA Approval of Generic Epipen Utilizing Vibex Auto Injector

01 Oct 2018
Antares Receives FDA Approval of XYOSTED™ (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males

30 Oct 2018
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results

06 Nov 2018
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results

08 Nov 2018
Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference

09 Nov 2018
Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting

26 Nov 2018
Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference

27 Nov 2018
Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen

29 Nov 2018
Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency

For Investors

Press Archive

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013


  • Sign up for breaking news on ATRS

    * indicates required